Sermorelin vs Ipamorelin: How Two Growth Hormone Peptides Compare in 2026

Sermorelin and ipamorelin both nudge your pituitary to release more of your own growth hormone, but they pull different levers. Sermorelin is a GHRH analogue: it copies the natural signal your body already uses. Ipamorelin is a GHRP that acts on the ghrelin receptor for a sharp, selective pulse. Sermorelin has the deeper regulatory track record and is the growth-hormone peptide pru offers today. Ipamorelin's compounding status is still unsettled. Looking into GH-support peptides is a proactive move, and choosing the right path matters more than the pick.

Sermorelin vs ipamorelin: what's the difference?

Sermorelin and ipamorelin are both growth-hormone (GH) peptides, but they work through two different receptors. Sermorelin is a GHRH analogue, meaning it copies growth-hormone-releasing hormone, the signal your own body uses to tell the pituitary to release GH. Ipamorelin is a GHRP, a growth-hormone-releasing peptide that acts on the ghrelin receptor instead.

Both are studied for supporting the body's own GH output rather than injecting GH directly. The practical difference for most people is availability: sermorelin was once an FDA-approved drug and is widely compounded today, while ipamorelin's compounding path is still being sorted out.

What are sermorelin and ipamorelin?

Sermorelin is a lab-made version of the first 29 amino acids of GHRH, the hormone your hypothalamus naturally uses to trigger growth-hormone release. Because it mirrors a signal your body already runs on, it's often described as working with your own rhythm. Ipamorelin is a five-amino-acid peptide (a pentapeptide) that belongs to a different family, the GHRPs, and it mimics ghrelin's action at the pituitary.

So the headline is GHRH vs GHRP. Sermorelin speaks the GHRH language; ipamorelin speaks the ghrelin language. Both conversations end at the same place, the pituitary releasing GH, but they start from different receptors. If you want the full primer on this whole family, see the growth hormone peptides guide and the sermorelin guide.

How do sermorelin and ipamorelin work differently?

Sermorelin works by binding the GHRH receptor on the pituitary and prompting a natural, pulsatile release of growth hormone, the same on-off pattern a younger body tends to produce. Ipamorelin works by binding the ghrelin (GHS-R1a) receptor, a separate switch that also tells the pituitary to fire, producing a clean, focused GH pulse.

The two pathways are complementary, not redundant. Sermorelin sets the physiologic tone; ipamorelin adds amplitude. This is why clinicians often think of GHRH-type and GHRP-type peptides as two levers rather than competitors. Neither one adds growth hormone from outside the body; both are thought to support your own production, which is a meaningful distinction from injected GH.

• Sermorelin: GHRH receptor -> mimics natural GH rhythm
• Ipamorelin: ghrelin receptor -> sharp, selective GH pulse
• Both: work upstream, encouraging your own pituitary rather than replacing GH

Which has the cleaner side-effect profile?

Both sermorelin and ipamorelin are considered selective, meaning they're studied for raising GH without meaningfully bumping other hormones. Ipamorelin is specifically known for this: unlike older GHRPs such as GHRP-6, it does not significantly raise cortisol, prolactin, or ACTH. That selectivity is a big part of why it became popular. Sermorelin, because it simply mimics GHRH, likewise tends not to spill over into those stress hormones.

Reported effects for both are usually mild and local, such as redness or irritation at the injection site, occasional flushing, or lightheadedness. This isn't a promise of how any one person will respond, and any GH peptide should be used under a prescriber. For sermorelin specifics, see sermorelin side effects. Peptides are studied for support; they aren't approved to treat, cure, or prevent any disease.

How do half-life and timing compare?

Half-life is where sermorelin and ipamorelin differ most on paper. Sermorelin clears fast, with a half-life around 10 to 20 minutes, which produces a short, natural GH pulse. Ipamorelin lasts longer, roughly two hours, so its GH signal stretches out. Neither number tells you a dose; it just explains why protocols and timing differ between the two.

In practice, both are typically taken by a small subcutaneous injection at night, since that's when the body's largest natural GH pulse happens and food is out of the way. Dosing is always individual and set by a prescriber. For how this looks in a real protocol, see sermorelin dosage and, on the GHRP side, the ipamorelin dosage primer.

Can sermorelin and ipamorelin be combined?

Yes, and the combination is the reason people compare these two in the first place. When a GHRH-type peptide and a GHRP are used together, they hit both levers at once, and the resulting GH pulse is often larger than either could produce alone. The most common version of this pairing uses a longer-acting GHRH analogue, CJC-1295, alongside ipamorelin.

That said, a stack isn't automatically better for a given person, and combining peptides raises more questions a prescriber needs to weigh. If you want to understand the classic pairing, read the CJC-1295 + ipamorelin stack explainer and the CJC-1295 guide. Sermorelin can stand on its own as the GHRH lever, which is part of why it's a straightforward starting point.

• GHRH lever (sermorelin or CJC-1295) sets a natural GH rhythm
• GHRP lever (ipamorelin) adds a selective pulse
• Together they can amplify the GH release beyond either alone
• Any stack should be built and monitored by a prescriber

Which one can you actually get in 2026?

Availability is the deciding factor for many people, and this is where sermorelin and ipamorelin split. Sermorelin has the deeper regulatory history: it was FDA-approved as Geref, first in 1990 as a diagnostic agent and again in 1997 for growth-hormone deficiency in children. The brand was voluntarily discontinued in 2008 for commercial reasons, not safety, and sermorelin is now compounded by licensed pharmacies. That history gives it one of the stronger footings among GH peptides.

Ipamorelin sits in a different spot. The FDA placed it in Category 2 of its interim 503A bulk-substance policy in 2023, and the advisory committee's 2024 review did not clear a path back. Ipamorelin isn't on the FDA's July 2026 PCAC agenda either. So while ipamorelin is well studied, its compounding access remains unsettled, which is why pru points GH-peptide interest toward sermorelin for now and watches the FDA's review as it develops.

Sermorelin or ipamorelin: which is right for you?

For most newcomers, sermorelin is the more practical starting point, because it's available through legitimate compounding today and carries a long clinical track record as a GHRH-type peptide. Ipamorelin is a strong GHRP with an excellent selectivity profile, but its unsettled compounding status makes it harder to obtain the right way in 2026.

You don't pick alone, and you shouldn't. With pru, you choose the peptide you're drawn to, guided by content like this, and a licensed physician confirms whether it fits your health picture. The doctor never gets handed a menu to choose from for you; they confirm fit and safety. If muscle, recovery, and performance are your goals, the best peptides for muscle growth overview and pru's Muscle & Performance catalog are good next stops.

• Want the most available, well-documented option today: sermorelin
• Curious about the selective GHRP pulse: ipamorelin, once access clears
• Chasing a bigger combined pulse: a GHRH + GHRP stack, prescriber-guided
• Unsure: start with sermorelin and let the physician confirm fit

How pru handles sermorelin (and ipamorelin)

pru is a telehealth platform for compounded peptides and closely related longevity therapies. A licensed physician reviews your intake and confirms whether a peptide fits; an FDA-regulated 503A pharmacy compounds and fills it. You select the peptide, guided by content like this page, and the physician confirms clinical fit, they don't pick between peptides for you.

Sermorelin is the growth-hormone peptide pru offers today, at the sermorelin product page. Ipamorelin isn't on pru's shelf yet; pru is watching the FDA's review before adding it, rather than routing anyone to grey-market vials. Pricing is simple: a flat membership funds the platform, and the medicine itself is priced at cost, itemized, with no markup.

Being proactive about how you age is a smart, responsible choice, and pru exists to make that choice the accessible one: licensed physicians, pharmacy-grade medicine, at-cost pricing on one path. Take the next step with sermorelin when you're ready, or see how pru's pricing works and the where to buy sermorelin guide.

Related reading

• The complete growth hormone peptides guide
• Sermorelin guide: what it is and who it's for
• Ipamorelin guide
• CJC-1295 + ipamorelin stack explained
• Best peptides for muscle growth
• Shop sermorelin at pru

Common questions